Intract Pharma
PrivateLast Round
Corporate Funding
Sep 16, 2024
Total Funding Raised
$3.87M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Intract Pharma operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Corporate Funding round in September 2024.
Intract Pharma is a biotechnology company that develops and licenses oral drug delivery technologies to replace injectable medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intract Pharma Comparables
Compare Intract Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Panarum Corp | 86% | |
| Bhami's Research Laboratory Private Limited | 83% | |
| Biograil | 83% |
For institutional investors. Book with your work email.
Intract Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Sep 16, 2024 | ||||
| Grant | May 28, 2024 | ||||
| Corporate Funding | May 26, 2020 | ||||
| Grant | Nov 9, 2018 | ||||
| Seed | Jan 11, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Intract Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eurostars SME programme | Grant |
| Innovate UK | Grant |
| UCL Business | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 116% MoM.
- Apr 18, 2026
Monthly visitors increased 305% MoM, reaching 4.7K.
For institutional investors. Book with your work email.
Intract Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Intract Pharma's valuation, stock price, and market status.
Is Intract Pharma a public or private company?
Intract Pharma is a private company.
What is the current stock price of Intract Pharma?
Intract Pharma is a private company, so its shares have no public market price. Caplight tracks Intract Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Intract Pharma worth (valuation)?
Valuation information for Intract Pharma is not publicly available.
Can I buy Intract Pharma stock?
Intract Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Intract Pharma's last funding round?
Intract Pharma's most recent funding round was Corporate Funding on September 16, 2024.
Who are the main investors in Intract Pharma?
Key investors in Intract Pharma include Eurostars SME programme, Innovate UK, UCL Business.
Will Intract Pharma IPO soon?
No public IPO plans have been announced for Intract Pharma.
How can I track Intract Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Intract Pharma's shares on secondary markets.